2,616 reports of this reaction
4.4% of all HYDRALAZINE HYDROCHLORIDE reports
#2 most reported adverse reaction
ACUTE KIDNEY INJURY is the #2 most commonly reported adverse reaction for HYDRALAZINE HYDROCHLORIDE, manufactured by Nivagen Pharmaceuticals, Inc.. There are 2,616 FDA adverse event reports linking HYDRALAZINE HYDROCHLORIDE to ACUTE KIDNEY INJURY. This represents approximately 4.4% of all 59,065 adverse event reports for this drug.
Patients taking HYDRALAZINE HYDROCHLORIDE who experience acute kidney injury should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ACUTE KIDNEY INJURY is moderately reported among HYDRALAZINE HYDROCHLORIDE users, representing a notable but not dominant share of adverse events.
In addition to acute kidney injury, the following adverse reactions have been reported for HYDRALAZINE HYDROCHLORIDE:
The following drugs have also been linked to acute kidney injury in FDA adverse event reports:
ACUTE KIDNEY INJURY has been reported as an adverse event in 2,616 FDA reports for HYDRALAZINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ACUTE KIDNEY INJURY accounts for approximately 4.4% of all adverse event reports for HYDRALAZINE HYDROCHLORIDE, making it one of the most commonly reported side effect.
If you experience acute kidney injury while taking HYDRALAZINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.